The goal of this study is to better understand the diagnosis pattern and treatment options of various autoimmune conditions, including autoimmune hemolytic anemia, immune thrombocytopenia, and chronic idiopathic/autoimmune neutropenia.
This study will examine both traditional and new diagnostic tools (i.e., cytokine assays, bone marrow evaluation, and fecal microbiome). Additionally, the type of treatment administered, its effectiveness, and adverse event rate will be studied. Blood tests will be performed to evaluate possible predictors of outcome. Participants will also be evaluated of their autoimmune condition evolving into myelodysplastic syndromes (a class of disorders caused by poorly formed or dysfunctional blood cells).
Participants 18 years and older with any of the conditions mentioned above who are available for a 3-year follow-up are eligible to enroll in this study.
Italy
Actively Recruiting